Why is Vaishali Pharma falling/rising?

As of 10-Sep, Vaishali Pharma Ltd's stock price is currently at 12.05, reflecting a decrease of 0.12 or 0.99%. The stock has underperformed its sector today by 1.37% and is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Over the past week, the stock has declined by 0.90%, and its year-to-date performance shows a significant drop of 31.10%. The company has also reported a concerning -145.73% CAGR growth in operating profits over the last five years, with a weak EBIT to interest ratio of 1.68, indicating challenges in servicing its debt. Additionally, the stock has generated a return of -36.99% over the past year, with profits falling by 43%, further contributing to its negative outlook.
In the broader market context, the Sensex has increased by 1.04% over the past week, contrasting sharply with Vaishali Pharma's decline. The stock's performance has lagged behind the benchmark, with a year-to-date return of -31.10% compared to the Sensex's gain of 5.62%. This underperformance is compounded by the company's flat results in June, where the profit after tax fell by 24.7%. The overall sentiment surrounding the stock remains negative due to its weak long-term fundamentals and below-par performance both in the near term and historically, leading to a classification as a strong sell.